JOEL HOEKSTRA’S 13 – Dying To Live

  • 7/10
    JOEL HOEKSTRA'S 13 - Dying To Live - 7/10
7/10

Summary

Frontiers Records
Release date: October 16, 2015

Sending
User Review
7.2/10 (5 votes)

Joel Hoekstra’s 13 is the side project of multi-faceted guitarist Joel Hoekstra, who’s best known for his work with Night Ranger, TSO, and Whitesnake, and Dying To Live is his debut record. Hoekstra’s Melodic Hard Rock band is jam-packed full of superstars in the industry, including Jeff Scott Soto and Russell Allen sharing vocal duties, Vinnie Appice pounding the drums, and Tony Franklin slapping the bass.

Dying To Live is a very introspective record filled with life’s struggles and (what appear to be personal) crossroads, which tends to tiresome as the album progresses, but there’s still plenty to enjoy here.

Author

  • Dan Skiba

    Dan is a former partner at Metal Express Radio, and also served as a reviewer, photographer and interviewer on occasions. Based out of Indianapolis, USA he was first turned on to Hard Rock music in the mid-1970s when he purchased Deep Purple's Machine Head as his first album. He was immediately enthralled with the powerful guitar sound and pronounced drumbeat, and had to get more! His collection quickly expanded to include as many of Heavy Rock bands of the time that he could get his hands on, such as Ted Nugent, Judas Priest, and Black Sabbath, to name just a few.

    View all posts

1 Comment

  1. Having listened to this album for the past 3 weeks, it is a very good AOR-type recording, albeit not quite as heavy as I usual listen to. With that said, the songwriting is quite good. If I had to pick favorite tracks, it would be the title track, Until I Left You , and Say Goodbye to the Sun being my favorites. Huge compliments to JSS & Russell for their work here also, very well done. For my listening ears, a 7/10 but those who like this style more may rate it higher.

Leave a Reply

Your email address will not be published.


*


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

The reCAPTCHA verification period has expired. Please reload the page.